Latest News for JMPLY
Johnson Matthey Plc (JMPLY) Q4 2026 Earnings Call Transcript
Johnson Matthey LON: JMAT reported higher underlying profit, improved margins and stronger cash generation for fiscal 2025/2026, while management outlined progress on a restructuring strategy, the pending sale of Catalyst Technologies and a new acquisition aimed at expanding its emissions-control business.
Johnson Matthey PLC's (LSE:JMAT) full-year results were broadly in line with the upgraded guidance the FTSE 100 specialty chemicals group had already provided, leaving the shares flat in early trading as investors focused instead on the $460 million Cormetech acquisition announced alongside the numbers. Panmure Liberum, which rates the stock a 'buy' with a 2310p target price, described the financial year to March…
British chemicals company Johnson Matthey said on Thursday it would buy Cormetech for $360 million, betting on growth in the U.S. power generation market amid strong demand for emission control at data centres.
Johnson Matthey PLC (LSE:JMAT), the FTSE 100 specialty chemicals group, is acquiring Cormetech, the leading US manufacturer of selective catalytic reduction (SCR) catalysts, for an enterprise value of $360 million in cash. An additional earn-out of up to $100 million may be payable in 2028 and 2029 if Cormetech hits certain financial targets.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for JMPLY.
Senate Trading
No Senate trades found for JMPLY.
U.S. House Trading
No House trades found for JMPLY.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.